4-硝基马尿酸, ≥99%,4-Nitrohippuric Acid

产品编号:西域试剂-WR184106| CAS NO:2645-07-0| MDL NO:MFCD00007349| 分子式:C9H8N2O5| 分子量:224.17

N-(4-硝基苯甲酰)甘氨酸是甘氨酸(HY-Y0966)衍生物。

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
西域试剂-WR184106
42.00 杭州 北京(现货)
西域试剂-WR184106
115.00 杭州 北京(现货)
西域试剂-WR184106
408.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

英文名称4-Nitrohippuric Acid
CAS编号2645-07-0
产品描述N-(4-硝基苯甲酰)甘氨酸是甘氨酸(HY-Y0966)衍生物。
产品熔点131-133 °C(lit.)
产品沸点531.2ºC at 760mmHg
产品密度1.467g/cm3
产品闪点275ºC
精确质量224.04300
PSA112.22000
LogP1.32330
蒸气压4.11E-12mmHg at 25°C
体外研究

氨基酸和氨基酸衍生物已被商业化用作能量补充剂。它们影响合成代谢激素的分泌、运动期间的燃料供应、压力相关任务期间的精神表现,并防止运动引起的肌肉损伤。它们被认为是有益的能生膳食物质。

稳定性

如果遵照规格使用和储存则不会分解。

储存条件

密封于阴凉干燥环境。

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


WGK德国 3
RTECS号 MC0785000
海关编码 2924299090
Name: 4-Nitrohippuric acid 98% Material Safety Data Sheet
Synonym: N-(4-Nitrobenzoyl)glycin
CAS: 2645-07-0
Section 1 - Chemical Product MSDS Name:4-Nitrohippuric acid 98% Material Safety Data Sheet
Synonym:N-(4-Nitrobenzoyl)glycin

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
2645-07-0 4-Nitrohippuric acid 98.0 220-156-5
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Exposure Limits CAS# 2645-07-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 131 - 133 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H8N2O5
Molecular Weight: 224.17

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 2645-07-0: MC0785000 LD50/LC50:
Not available.
Carcinogenicity:
4-Nitrohippuric acid - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 2645-07-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 2645-07-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 2645-07-0 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

~64%

2645-07-0结构式

2645-07-0

文献:F2G LTD Patent: WO2008/62182 A1, 2008 ; Location in patent: Page/Page column 153 ;

~83%

2645-07-0结构式

2645-07-0

文献:Barati, Behjat; Moghadam, Majid; Rahmati, Abbas; Tangestaninejad, Shahram; Mirkhani, Valiollah; Mohammadpoor-Baltork, Iraj Synlett, 2013 , vol. 24, # 1 p. 90 - 96

~86%

2645-07-0结构式

2645-07-0

文献:Jursic; Neumann Synthetic Communications, 2001 , vol. 31, # 4 p. 555 - 564

~%

2645-07-0结构式

2645-07-0

文献:DeRuiter, Jack; Swearingen, Blake E.; Wandrekar, Vinay; Mayfield, Charles A. Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 1033 - 1038

~%

2645-07-0结构式

2645-07-0

文献:Curran, Terence C; Farrar, Charles R.; Niazy, Omima; Williams, Andrew Journal of the American Chemical Society, 1980 , vol. 102, # 22 p. 6828 - 6837

~%

2645-07-0结构式

2645-07-0

文献:Lebedukho; Kuritsyn; Sadovnikov Russian Journal of General Chemistry, 2004 , vol. 74, # 2 p. 222 - 224

~%

2645-07-0结构式

2645-07-0

文献:Um, Ik-Hwan; Chung, Eun-Kyung; Lee, So-Mi Canadian Journal of Chemistry, 1998 , vol. 76, # 6 p. 729 - 737

服务热线

13911702513
18601927057

微信客服